Home › Esophageal Cancer › Texas › Austin
Esophageal Cancer clinical trials in Austin, TX
3 studies for Esophageal Cancer are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RecruitingPhase 1
- NEXT Austin, Austin
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecruitingPhase 1
- NEXT Oncology Austin /ID# 243005, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- Elligo Health Research, Inc., Austin
About Esophageal Cancer
Early esophageal cancer does not have symptoms. Factors that increase risk include heavy drinking and smoking. Learn how you can reduce your risk.
More about Esophageal Cancer on MedlinePlus
Esophageal Cancer trials in other cities
- Houston, TX36 studies
- Boston, MA23 studies
- New York City, NY22 studies
- Nashville, TN19 studies
- St. Louis, MO17 studies
- Pittsburgh, PA15 studies
- Los Angeles, CA15 studies
- Grand Rapids, MI14 studies
- Baldwin Park, CA14 studies
- Philadelphia, PA13 studies
- San Antonio, TX12 studies
- Chicago, IL11 studies
Other studies in Austin
- Non-Small Cell Lung Cancer30 studies
- Cancer (all types)20 studies
- Obesity20 studies
- Colorectal Cancer19 studies
- Metastatic Cancer19 studies
- Overweight18 studies
- Heart Failure18 studies
- Breast Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer15 studies
- Prostate Cancer15 studies
- Depression14 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.